Works matching IS 02780232 AND DT 2024 AND VI 42 AND IP 2

Results: 15

The role of baseline 2‐[<sup>18</sup>F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3266

By:

Albano, Domenico;
Calabrò, Anna;
Dondi, Francesco;
Bagnasco, Samuele;
Tucci, Alessandra;
Bertagna, Francesco

Publication type:

Article

Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3259

By:

Duminuco, Andrea;
Nardo, Antonella;
Palumbo, Giuseppe A.

Publication type:

Article

Mortality associated to hematological malignancies across pandemic waves in 2020: A nationwide analysis of multiple causes of death in Italy.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3263

By:

Grande, Enrico;
Grippo, Francesco;
Barbiellini Amidei, Claudio;
Fedeli, Ugo;
Tosetto, Alberto

Publication type:

Article

New insights into the Bortezomib‐induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3262

By:

Romeo, Maria Anele;
Focaccetti, Chiara;
Arena, Andrea;
Benedetti, Rossella;
Di Crosta, Michele;
Palumbo, Camilla;
Gilardini Montani, Maria Saveria;
Santarelli, Roberta;
Gonnella, Roberta;
D'Orazi, Gabriella;
Bei, Roberto;
Cirone, Mara

Publication type:

Article

Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3261

By:

Abenavoli, Elisabetta M.;
Linguanti, Flavia;
Anichini, Matilde;
Miele, Vittorio;
Mungai, Francesco;
Palazzo, Marianna;
Nassi, Luca;
Puccini, Benedetta;
Romano, Ilaria;
Sordi, Benedetta;
Sciagrà, Roberto;
Simontacchi, Gabriele;
Vannucchi, Alessandro M.;
Berti, Valentina

Publication type:

Article

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3260

By:

Wang, Rong;
Zhang, Yi;
Chang, Jie;
Wang, Huafeng;
Lou, Yinjun;
Yang, Min;
Xu, Gaixiang;
Tong, Hongyan;
Xie, Wanzhuo;
Zhou, De;
Wei, Juying;
Mai, Wenyuan;
Ye, Xiujin;
Meng, Haitao;
Jin, Jie;
Zhu, Hong‐Hu

Publication type:

Article

Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3264

By:

Sun, Yuan;
Wang, Xu;
Chen, Wen‐Min;
Hao, Yue;
Li, Ling‐Di;
Li, Jin‐Ying;
Sun, Kai;
Shi, Zong‐Yan;
Jiang, Hao;
Jiang, Qian;
Huang, Xiao‐Jun;
Qin, Ya‐Zhen

Publication type:

Article

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long‐term outcomes in the Phase 3 IKEMA study.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3258

By:

Facon, Thierry;
Moreau, Philippe;
Špicka, Ivan;
Suzuki, Kenshi;
Yong, Kwee;
Mikhael, Joseph;
Fukao, Taro;
Bisht, Kamlesh;
Armstrong, Nicole M.;
Macé, Sandrine;
Risse, Marie‐Laure;
Martin, Thomas

Publication type:

Article

Antibody targeting of surface P‐selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3257

By:

Pereira, João L.;
Ferreira, Francisca;
dos Santos, Nuno R.

Publication type:

Article

Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt‐related transcription factor 1 mutation: A single‐center retrospective analysis.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3256

By:

Wang, Lin‐Ya;
Li, Yao;
Jiang, Qian;
Jiang, Hao;
Wang, Yu;
Xu, Lan‐Ping;
Zhang, Xiao‐Hui;
Liu, Kai‐Yan;
Tang, Fei‐Fei

Publication type:

Article

Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus‐based position paper from an ad hoc expert panel.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3255

By:

Mauro, Francesca Romana;
Tedeschi, Alessandra;
Varettoni, Marzia;
Zaja, Francesco;
Barosi, Giovanni;
Zinzani, Pier Luigi

Publication type:

Article

Treatment‐related toxicity disparities in adult Hispanic acute lymphoblastic leukemia patients receiving pegaspargase‐based regimens: A multicenter electronic health research network study.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3254

By:

Lee, Benjamin J.;
Griffin, Shawn P.

Publication type:

Article

How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3250

By:

Mouawad, Nayla;
Ruggeri, Edoardo;
Capasso, Guido;
Martinello, Leonardo;
Visentin, Andrea;
Frezzato, Federica;
Trentin, Livio

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3178
Publication type:: Article

Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3253

By:

Virijevic, Marijana;
Kraguljac‐Kurtovic, Nada;
Mitrovic, Mirjana;
Jakovic, Ljubomir;
Bukumuric, Zoran;
Pantic, Nikola;
Sabljic, Nikica;
Pravdic, Zlatko;
Cvetkovic, Mirjana;
Knezevic, Vesna;
Dragovic‐Ivancevic, Tijana;
Djunić, Irena;
Rajic, Jovan;
Milosevic, Violeta;
Todorovic‐Balint, Milena;
Vidovic, Ana;
Suvajdzic‐Vukovic, Nada

Publication type:

Article